Navigation Links
CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO
Date:1/15/2009

SACRAMENTO, Calif., Jan. 15 /PRNewswire/ -- CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its ROBODOC(R) Surgical System, announced the addition of Brent D. Mittelstadt to its senior management team as President and Chief Executive Officer.

Mr. Mittelstadt began research in surgical robotics in 1986 as a visiting research scientist at the IBM T.J. Watson Research Center and is responsible for much of the early development of CT guided robotic systems for joint replacement surgery. In 1990, with initial investment from IBM, Mr. Mittelstadt co-founded Integrated Surgical Systems (ISS) to develop a surgical robot system to assist with hip and knee replacement surgery. In 2007, ISS with the approval of its shareholders transferred all of its assets to CUREXO Technology Corporation.

While at ISS, Mr. Mittelstadt served as Director of Surgical Applications, where he led the development and refinement of both the early pin based hip application, as well as the DigiMatch(TM) ROBODOC(R) Surgical System for Total Hip Arthroplasty (THA), which received U.S. Food and Drug Administration (FDA) clearance in August, 2008.

After leaving ISS in June 2002, Mr. Mittelstadt took a position at Consensus Orthopedics (formerly Hayes Medical Inc.), where he was Director of Marketing. Mr. Mittelstadt was part of a "turn around" management team that was integral in transforming the company. When Mr. Mittelstadt first jointed Consensus Orthopedics, it was suffering from declining sales and a poor reputation in the market. Today, Consensus Orthopedics is achieving over 60% annual growth in revenue. While at Consensus Orthopedics, Mr. Mittelstadt was involved in the development of new implants and line extensions as well as re- designing the total knee instrumentation system to address changes in the joint replacement market.

Mr. Mittelstadt received a B.S. in Biology from the University of Arizona in 1984. He holds 8 patents and has published extensively in the field of Computer Assisted Orthopedic Surgery.

"We are very excited to have Mr. Mittelstadt as a member of our senior management team. The unique combination of his ROBODOC knowledge and our recent FDA clearance provides Mr. Mittelstadt an immense opportunity to lead the company into the next phase of commercializing our products into the U.S. market. Mr. Mittelstadt brings his vast robotic experience along with integrity and vision to the company," stated Mr. Taehoon Kim, Chairman of CUREXO Technology Corporation.

About CUREXO Technology Corporation

CUREXO Technology Corporation, develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC(R) Surgical System includes two components; ORTHODOC(R), a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC(R) Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries.

The DigiMatch(TM) ROBODOC(R) Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only computer- controlled robotic system cleared by the FDA for orthopedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC(R), ORTHODOC(R), and DigiMatch(TM) are registered trademarks of CUREXO Technology Corporation. For more information, visit http://www.robodoc.com.

     Contact:

     Ms. Sheila Shah
     Marketing Communications
     CUREXO Technology Corporation
     916 285 9943 X 510
     press@robodoc.com

'/>"/>
SOURCE CUREXO Technology Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Healthcare Providers Choosing IVANS High-Speed Technology to Succeed Within Medicare Modernization Era
2. PFCD Experts Cite Health Information Technology as Key Investment for Economic Stimulus
3. Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center
4. InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
5. MEMOTEXT Collaborating with Johns Hopkins University To Evaluate Technology-Driven Adherence Programs
6. URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
7. URMC, Lighthouse Biosciences awarded US patent for diagnostic technology
8. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
9. Interactive Report Maps Landscape of Technology for the Aging
10. Press Ganey Acquires PatientFlow Technology
11. Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial ... treatment. Dr. Stong is double board certified and the only facial plastic surgeon ... of hair loss. Non-surgical therapies such as stem cells can be used to provide ...
(Date:5/5/2016)... ... May 05, 2016 , ... In honor of National Nurses ... people all over the United States to thank a nurse who's made a difference ... donate $5 to the American Red Cross of San Diego/Imperial Counties (up to $10,000) ...
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a silent, ... can weaken the immune system and increase inflammation, both of which raise the risk ... adult congenital heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can ...
(Date:5/5/2016)... N.J. (PRWEB) , ... May 05, 2016 , ... ... patients with cancer, today announced a new collaboration with Imerman Angels to ... cancer anywhere in the world. , “Imerman Angels provides an emotional lifeline to patients ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dermatologic surgeons performed nearly 10 million ... up 27 percent since 2012. , The results of the 2015 ASDS Survey on ... in skin cancer treatments and the growing popularity of soft-tissue fillers and body sculpting ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016  Compass Diversified Holdings (NYSE: CODI ... of leading middle market businesses, announced today its consolidated ... 2016. First Quarter 2016 Highlights , ... or "Cash Flow") of $13.6 million for the first ... $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
Breaking Medicine Technology: